Dove,

 

 

Fund for 2DAX EMS OER KOM |
integrative SUNK XKNIX
Biomedical WREKIN OOO OIE 1742 N Street, N.W.
Research 202.293.7660

William Regelson, M.D.

Scientific Director

Paul Leventhal

Executive Director

Board of Directors
Harvey Silbert

President

Marcus H. Rabwin, M.D.

Vice President

Mrs. Alan Cranston
Secretary & Treasurer

Vincent V. Abajian

Mrs. Marjorie Benton
Bernard Bergreen

Mrs. Nancie Brooke Knapp
Mrs. Albert D. Lasker
Robert Peterson

Mrs. Lyn Revson

Miles Rubin

Mary Carol Rudin

Scientific Advisory Board
Marcus H. Rabwin, M.D.

Chairman
Science Advisory Board

Harry Demopoulos, M.D.
Associate Protessor of Pathology
New York University

Medical Center

William Doering, Ph.D.
Mallinkrodt Professor of Chemistry
Harvard University

Allan Goldstein, Ph.D.
Chairman, Department

of Biochemistry

School of Medicine

George Washington University

Joshua Lederberg, Ph.D.
President
Rockefeller University

Cart Merril, M.D.
Research Scientist

Laboratory of General

and Comparative Biochemistry
National Institute

of Mental Health

Erwin Pachter, M.D.
Director of Research
Bristol Laboratories

Albert Rosenfeld
Consultant on Future Programs
March of Dimes

Birth Defects Foundation

Lewis Thomas, M.D.
Chancellor

Memorial Sloan-Kettering
Cancer Center

F. Marott Sinex, Ph.D.
Professor of Biochemistry
Boston University

James Weisiger, Ph.D.
Director

Scientific Evaluation Program
National Institute of

Arthritis, Metabolism and
Digestive Diseases

Jerry Williams, Ph.D.
Professor

of Radiology and Pharmacology
School of Medicine

George Washington University

CAS FS

Washington, D.C.
April 14, 198]

20036

  

Dr. Joshua Lederberg
President

Rockefeller University
1230 York Avenue

New York, NY 10021

Dear Dr. Lederberg,

I am pleased to invite you to attend the first meeting of
FIBER's Science Advisory Board in 1981. The meeting will take
place on Friday, May 8 in the Conference Room of our new head-
quarters at 1742 N Street, N.W., beginning at 9:30 AM.

Having just recently come on board as Executive Director, I
consider this an extremely important meeting for the opportunity
to have an exchange of ideas on how FIBER can fulfill its promise
as a catalyst in aging research. Establishment of priorities is
an essential objective in FIBER's second year. We will be
emphasizing implementation of anti-aging research and strategies
that were identified during FIBER's first year.

FIBER's success depends on an active and involved Science
Advisory Board dealing both with the science of aging and the
policies of FIBER. The attached agenda is intended to give members
of the Science Advisory Board their first opportunity this year to
meet aS a group and to consider both.

As you can see from the agenda, we are planning a full-day pro-
gram with several presentations and ample time for discussion.
Senator Cranston will be at the meeting and have opening remarks.

We will have a rapporteur, and minutes of the meeting will be
distributed to members both of the Science Advisory Board and of

the Board of Directors. We plan to have regularly scheduled meetings
of the Science Advisory Board at intervals and consistent with a
format to be decided at this initial session.

There will be a buffet lunch in the conference room and a
cocktail reception at the end of the day. Of course, FIBER will
reimburse transportation, hotel and other expenses in connection
with this and subsequent meetings of the Science Advisory Board.

3
6
tS
cr
oo
of

7
3
CG
cr
Gg

The Fund for Integrative Biomedical Research is a tax-exempt public charity. Your contributions are deductible
-?2.-

Bill Regelson and I are looking forward to this meeting. Please let
me know at your earliest convenience whether you will attend and whether
we can be of assistance in arranging your accommodations.

(Lib)

Paul Leventhal
Executive Director

PL/jf
Enclosure

 

FIiDER